Home > Boards > US Listed > Medical - Healthcare > GENPREX (GNPX)

News: $GNPX NetworkNewsBreaks - Genprex, Inc. (NASDAQ: GNPX)

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 57
Posts 7,111
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 12/10/2019 5:27:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/22/2019 4:05:54 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/22/2019 3:59:22 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/22/2019 9:23:25 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/21/2019 4:07:35 PM
Genprex Announces $1.26 Million Registered Direct Offering Business Wire - 11/20/2019 11:15:00 AM
Genprex Reports Positive Preclinical Data for the Treatment of Some of the Most Resistant Metastatic Lung Cancers Business Wire - 11/19/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 12:10:02 PM
Genprex Issues Lung Cancer Prevention Measures in Support of Lung Cancer Awareness Month Business Wire - 11/4/2019 8:00:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/29/2019 6:01:04 AM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 10/16/2019 5:25:59 PM
Amended Quarterly Report (10-q/a) Edgar (US Regulatory) - 10/16/2019 5:25:27 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 10/16/2019 5:24:57 PM
Genprex to Present at the MicroCap Rodeo Investor Conference Business Wire - 10/9/2019 8:00:00 AM
Genprex’s Pioneering Use of Non-Viral Delivery for Gene Therapy is Gaining Industry Support Business Wire - 10/7/2019 8:00:00 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 10/4/2019 4:00:31 PM
Genprex (GNPX) Featured in Audio Publication Discussing New Research on Breast Cancer Treatment GlobeNewswire Inc. - 9/26/2019 8:30:00 AM
Genprex (GNPX) Featured in Publication on Advances in Potential Breast Cancer Treatments GlobeNewswire Inc. - 9/25/2019 8:30:00 AM
Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers NetworkNewsWire - 9/24/2019 8:45:00 AM
Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019 Business Wire - 9/18/2019 8:00:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/16/2019 6:02:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2019 1:23:20 PM
Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer Business Wire - 9/11/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/9/2019 1:12:33 PM
CORRECTING and REPLACING Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference Business Wire - 9/7/2019 4:35:00 PM
whytestocks Member Level  Tuesday, 11/19/19 11:19:05 AM
Re: None
Post # of 77 
News: $GNPX NetworkNewsBreaks - Genprex, Inc. (NASDAQ: GNPX) Reports Preclinical Data Showing Positive Results for Treatment of Resistant Metastatic Lung Cancers

Genprex (NASDAQ: GNPX) , a clinical-stage gene therapy company, today announced that its collaborators from The University of Texas MD Anderson Cancer Center (“MD Anderson”) presented positive preclinical data at the American Association of Cancer Research Tumor Immunology and I...

Find out more GNPX - NetworkNewsBreaks - Genprex, Inc. (NASDAQ: GNPX) Reports Preclinical Data Showing Positive Results for Treatment of Resistant Metastatic Lung Cancers

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist